Analyst consensus rating
Harvard Bioscience Analyst Rating: Hold
Direct answer
Harvard Bioscience's consensus rating is Hold.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $13.00.
Forecast evidence checked November 14, 2026.
Get free Harvard Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.39
- Average price target
- $13.00
- High price target
- $13.00
- Low price target
- $13.00
- Low target gap
- +38.4%
- Target upside
- +38.4%
- High target gap
- +38.4%
- Target range width
- 0%
- Consensus rating
- Hold
- Analysts
- 1
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Harvard Bioscience?
Harvard Bioscience has a verified Hold consensus. The same dataset has an average price target of $13.00.
How far are Harvard Bioscience's low and high targets from the recorded price?
The low target implies +38.4%, while the high target implies +38.4%.
How many analysts are included in Harvard Bioscience's consensus?
The verified consensus includes 1 analysts.
How is Harvard Bioscience's target upside or downside calculated?
The average target of $13.00 is divided by the recorded price of $9.39, then one is subtracted to produce +38.4%. This does not guarantee a future return.
When was Harvard Bioscience's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.